A 1-year retrospective review of ranibizumab for naïve nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration

Retina

Volumn 29, Issue 10, 2009, Pages 1444-1449

  Arias, Luis ^a,b   Ruiz Moreno, Jose M ^c,d   Gómez Ulla, Francisco ^e   Fernández, Maribel ^e   Montero, Javier ^d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CENTRO MÉDICO TEKNON   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^d Alicante   (Spain)

^e UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE INFLAMMATION; FEMALE; HUMAN; MALE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HOLE; STAPHYLOCOCCUS EPIDERMIDIS; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; CLINICAL TRIAL; DRUG ANTAGONISM; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; INJECTION; MIDDLE AGED; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA MACULA DEGENERATION; RETREATMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VITREOUS BODY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 73349093467     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ae712d     Document Type: Article

References (14)

1. Age-Related Eye Disease Study (AREDS) Research Group. Potential public health impact of Age-Related Eye Disease Study Results: AREDS Report No. 11. Arch Ophthalmol 2003;121:1621-1624.
2. Beaumont PE, Kang HK. Lesion morphology in age-related macular degeneration and its therapeutic significance. Arch Ophthalmol 2006;124:807-812.
3. Olsen TW, Feng X, Kasper TJ, Rath PP, Steuer ER. Fluorescein angiographic lesion type frequency in neovascular agerelated macular degeneration. Ophthalmology 2004;111:250-255. (Pubitemid 38183223)
4. Chakravarthy U, Soubrane G, Bandello F, et al. Evolving European guidance on the medical management of neovascular age-related macular degeneration. Br J Ophthalmol 2006; 90:1188-1196.
5. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina 2005;25:685-690.
6. Mones JM, Lopez MA, Prieto JA, Rodriguez JP. Extrafoveal choroidal neovascularization secondary to wet age-related macular degeneration treated with intravitreal bevacizumab. Ophthalmic Surg Lasers Imaging 2007;38:226-228.
7. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
8. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006;355:1432-1444.
9. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy after five years. Results from randomized clinical trials. Arch Ophthalmol 1991;109: 1109-1114.
10. Macular Photocoagulation Study Group. Persistent and recurrent neovascularization after krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Arch Ophthalmol 1990;108:825-831.
11. Blair MP, Apte RS, Miskala PH, et al. Retrospective case series of juxtafoveal choroidal neovascularization treated with photodynamic therapy with verteporfin. Retina 2004;24:501-506.
12. Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007;144:850-857.
13. Pilli S, Kotsolis A, Spaide RF, et al. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting. Am J Ophthalmol 2008; 145:879-882.
14. Quaranta-El Maftouhi M, Mauget-Faysse M. Anomalous vitreoretinal adhesions in patients with exudative age-related macular degeneration: An OCT study. Eur J Ophthalmol 2006; 16:134-137.